BRIGHAM AND WOMEN'S HOSPITAL
Elucidating Treg defects in ALS
Elucidating Treg defects in ALS is a funding opportunity from BRIGHAM AND WOMEN'S HOSPITAL, up to 823143, closing January 31, 2031.
Jan 31, 2031
(1645d left)Overview
1 There is a significant unmet need to identify disease ameliorating therapies for the treatment of ALS. It is 2 increasingly recognized that neuroinflammation plays a central role in driving the ALS progression. Regulatory 3 T cells (Tregs) are a lineage of CD4 T cells that regulate homeostasis by inhibiting…